The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE-/- Mouse Model

被引：0
|
作者：
Simpson, Richard W.
Gaspari, Tracey
Welungoda, Iresha
Widdop, Robert E.
Knudsen, Lotte B.
Dear, Anthony E.
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1896-P
引用
收藏
页码：A486 / A486
页数：1
相关论文
共 50 条
  • [11] Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis
    Dixit, Tejashree S.
    Sharma, Ajaykumar N.
    Lucot, James B.
    Elased, Khalid M.
    PHYSIOLOGY & BEHAVIOR, 2013, 114 : 38 - 41
  • [12] The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease
    Maskery, Mark
    Goulding, Elizabeth Mary
    Gengler, Simon
    Melchiorsen, Josefine Ulrikke
    Rosenkilde, Mette Marie
    Holscher, Christian
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2020, 35
  • [13] Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel
    Reiner, Johannes
    Berlin, Peggy
    Held, Jascha
    Thiery, Johanna
    Skarbaliene, Jolanta
    Griffin, Jonathan
    Russell, Wayne
    Eriksson, Per-Olof
    Berner-Hansen, Mark
    Ehlers, Luise
    Vollmar, Brigitte
    Jaster, Robert
    Witte, Maria
    Lamprecht, Georg
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2022, 46 (05) : 1107 - 1118
  • [14] Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
    Ismail, Ruba
    Bocsik, Alexandra
    Katona, Gabor
    Grof, Ilona
    Deli, Maria A.
    Csoka, Ildiko
    PHARMACEUTICS, 2019, 11 (11)
  • [15] The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism
    Zhang, Yikai
    Xie, Yi
    Xia, Shenglong
    Ge, Xinnuo
    Li, Jiaying
    Liu, Fang
    Jia, Fan
    Wang, Shengyao
    Zhou, Qiao
    Gao, Menghan
    Fang, Weihuan
    Zheng, Chao
    ADVANCED SCIENCE, 2025,
  • [16] GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE-/- Mice
    Panjwani, Naim
    Mulvihill, Erin E.
    Longuet, Christine
    Yusta, Bernardo
    Campbell, Jonathan E.
    Brown, Theodore J.
    Streutker, Catherine
    Holland, Dianne
    Cao, Xiemin
    Baggio, Laurie L.
    Drucker, Daniel J.
    ENDOCRINOLOGY, 2013, 154 (01) : 127 - 139
  • [17] Superior Efficacy of a Dual GLP-1/Glucagon Receptor Agonist in Reversing Steatosis and Improving Indices of Nonalcoholic Steatohepatitis (NASH) Compared with GLP-1 Receptor and FXR Agonists in a Mouse Model of NASH
    Trevaskis, James L.
    Jouihan, Hani
    Bednarek, Maria
    Veidal, Sanne S.
    Feigh, Michael
    Knudsen, Sanne M.
    Jelsing, Jacob
    Vrang, Niels
    Konkar, Anish
    Grimsby, Joseph
    Rondinone, Cristina
    Jermutus, Lutz
    DIABETES, 2016, 65 : A19 - A19
  • [18] The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease
    Hansen, Henrik H.
    Fabricius, Katrine
    Barkholt, Pernille
    Niehoff, Michael L.
    Morley, John E.
    Jelsing, Jacob
    Pyke, Charles
    Knudsen, Lotte Bjerre
    Farr, Susan A.
    Vrang, Niels
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 46 (04) : 877 - 888
  • [19] The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
    Hansen, Henrik H.
    Barkholt, Pernille
    Fabricius, Katrine
    Jelsing, Jacob
    Terwel, Dick
    Pyke, Charles
    Knudsen, Lotte Bjerre
    Vrang, Niels
    BRAIN RESEARCH, 2016, 1634 : 158 - 170
  • [20] LIRAGLUTIDE, A NOVEL GLP-1 ANALOGUE, PREVENTS THE IMPAIRMENT OF LEARNING AND LTP AND PLAQUE FORMATION IN AN APP/PS-1 MOUSE MODEL OF ALZHEIMER'S DISEASE
    McClean, P. L.
    Parthasarathy, V.
    Gault, V. A.
    Hoelscher, C.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : 24 - 24
12345